Judge approves FDA plan to drop limits on morning after pill
By Karen Freifeld and Bernard Vaughan NEW YORK (Reuters) - A U.S. district court judge on Wednesday approved a U.S. Food and Drug Ad...
Read More »
By Karen Freifeld and Bernard Vaughan NEW YORK (Reuters) - A U.S. district court judge on Wednesday approved a U.S. Food and Drug Ad...
Read More »By Bill Berkrot NEW YORK (Reuters) - Global drugmakers said on Wednesday they would cooperate with an independent review to address ...
Read More »By Kathryn Doyle NEW YORK (Reuters Health) - Programs designed to prevent childhood obesity in the home don't affect kids' weight a ...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Men with restless legs syndrome (RLS) were more likely to die during an eight-year st...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - A device that plays a melody in an attempt to slow people's breathing didn't lower t...
Read More »
By Julie Steenhuysen CHICAGO (Reuters) - A daily dose of powerful anti-HIV medicine helped cut the risk of infection with the AIDS v...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - A cap on soda size - such as the one New York City regulators are trying to pass - wo...
Read More »(Reuters) - Amgen Inc's trebananib drug for ovarian cancer extended the length of time that patients lived without the disease getti...
Read More »
By Pallavi Ail (Reuters) - Pfizer Inc said Teva Pharmaceuticals Industries Ltd and Sun Pharmaceutical Industries Ltd would pay $2.15...
Read More »
By Ben Hirschler LONDON (Reuters) - Britain is to regulate electronic cigarettes as non-prescription medicines from 2016 in an attem...
Read More »